Trial Profile
Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharygeal colonization with streptococcus pneumoniae in children and parents in the Netherlands
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 06 Jun 2010 Status changed from recruiting to completed as reported by Netherlands Clinical Trials Register record.
- 07 Jan 2009 New trial record.